I agree with some of this, but the other element I see is there looks to be some sector-related influence... take a look at the recent performance of some of the other junior oncology stocks for example - e.g. BD1, IMM, IMU. Some of this sector weakness may be related to the recent CR's announced by these companies - creating negative sentiment, selling 'similar' stocks to free up funds to participate, etc.
I agree with some of this, but the other element I see is there...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
-0.015(1.15%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $1.33 | $1.35 | $1.28 | $34.20K | 26.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1975 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 1824 | 1 |
View Market Depth
| Last trade - 16.10pm 24/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.31 |
Change
-0.015 ( 0.38 %) |
||||
| Open | High | Low | Volume | ||
| $1.32 | $1.35 | $1.28 | 9710 | ||
| Last updated 15.59pm 24/04/2024 ? | |||||
| RAC (ASX) Chart |